These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 32621327)
21. Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency. Gasco V; Giannelli J; Campioni L; Arvat E; Ghigo E; Grottoli S; Maccario M; Giordano R J Endocrinol Invest; 2023 Mar; 46(3):587-597. PubMed ID: 36251244 [TBL] [Abstract][Full Text] [Related]
22. Is physiological glucocorticoid replacement important in children? Porter J; Blair J; Ross RJ Arch Dis Child; 2017 Feb; 102(2):199-205. PubMed ID: 27582458 [TBL] [Abstract][Full Text] [Related]
23. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia. Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702 [TBL] [Abstract][Full Text] [Related]
24. Mortality Risk in Patients With Adrenal Insufficiency Using Prednisolone or Hydrocortisone: A Retrospective Cohort Study. Ngaosuwan K; Johnston DG; Godsland IF; Cox J; Majeed A; Quint JK; Oliver N; Robinson S J Clin Endocrinol Metab; 2021 Jul; 106(8):2242-2251. PubMed ID: 33993277 [TBL] [Abstract][Full Text] [Related]
25. Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis. Nowotny H; Ahmed SF; Bensing S; Beun JG; Brösamle M; Chifu I; Claahsen van der Grinten H; Clemente M; Falhammar H; Hahner S; Husebye E; Kristensen J; Loli P; Lajic S; Reisch N; Endocrine; 2021 Mar; 71(3):586-594. PubMed ID: 33661460 [TBL] [Abstract][Full Text] [Related]
26. The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency. Suliman AM; Freaney R; Smith TP; McBrinn Y; Murray B; McKenna TJ Clin Endocrinol (Oxf); 2003 Sep; 59(3):380-7. PubMed ID: 12919163 [TBL] [Abstract][Full Text] [Related]
27. Secondary adrenal insufficiency: from the physiopathology to the possible role of modified-release hydrocortisone treatment. Paragliola RM; Corsello SM Minerva Endocrinol; 2018 Jun; 43(2):183-197. PubMed ID: 28750490 [TBL] [Abstract][Full Text] [Related]
28. Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease. Giordano R; Guaraldi F; Marinazzo E; Fumarola F; Rampino A; Berardelli R; Karamouzis I; Lucchiari M; Manetta T; Mengozzi G; Arvat E; Ghigo E Endocrine; 2016 Feb; 51(2):360-8. PubMed ID: 26184416 [TBL] [Abstract][Full Text] [Related]
29. Optimal glucocorticoid therapy. Debono M; Ross RJ Endocr Dev; 2011; 20():173-180. PubMed ID: 21164270 [TBL] [Abstract][Full Text] [Related]
30. Optimal glucocorticoid replacement in adrenal insufficiency. Øksnes M; Ross R; Løvås K Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):3-15. PubMed ID: 25617168 [TBL] [Abstract][Full Text] [Related]